Compare VMD & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VMD | AQST |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 351.6M | 529.4M |
| IPO Year | 2018 | 2007 |
| Metric | VMD | AQST |
|---|---|---|
| Price | $8.62 | $3.71 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $12.00 | $9.33 |
| AVG Volume (30 Days) | 176.9K | ★ 2.2M |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.14 | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $270,280,000.00 | $67,430,000.00 |
| Revenue This Year | $17.63 | $11.13 |
| Revenue Next Year | $11.23 | $40.69 |
| P/E Ratio | $37.33 | ★ N/A |
| Revenue Growth | ★ 20.52 | 0.77 |
| 52 Week Low | $6.31 | $2.94 |
| 52 Week High | $12.61 | $6.74 |
| Indicator | VMD | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 36.19 | 42.49 |
| Support Level | $8.57 | $3.59 |
| Resistance Level | $10.07 | $4.34 |
| Average True Range (ATR) | 0.35 | 0.24 |
| MACD | -0.08 | 0.03 |
| Stochastic Oscillator | 5.07 | 47.41 |
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.